Similar articles for PMID: 20393096

Year	Number of Results
1996	1
1997	2
2000	2
2001	3
2002	2
2007	4
2008	6
2009	1
2010	8
2011	8
2012	6
2013	5
2014	7
2015	6
2019	1
2021	0

1

Genetics: factor V Leiden.

Cremin C, Carroll JC, Allanson J, Blaine SM, Dorman H, Gibbons CA, Honeywell C, Meschino WS, Permaul J, Wilson BJ. Cremin C, et al. Can Fam Physician. 2010 Apr;56(4):353. Can Fam Physician. 2010. PMID: 20393096 Free PMC article. No abstract available.

2

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.

Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG. Sode BF, et al. CMAJ. 2013 Mar 19;185(5):E229-37. doi: 10.1503/cmaj.121636. Epub 2013 Feb 4. CMAJ. 2013. PMID: 23382263 Free PMC article.

3

Risk factors and clinical presentation of venous thromboembolism according to the age of relatives of patients with factor V Leiden.

Couturaud F, Leroyer C, Mottier D; Groupe dEtude de la Thrombose de Bretagne Occidentale (G.E.T.B.O). Couturaud F, et al. Thromb Haemost. 2008 Apr;99(4):793-4. doi: 10.1160/TH07-12-0720. Thromb Haemost. 2008. PMID: 18392344 No abstract available.

4

Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.

Gadelha T, Roldán V, Lecumberri R, Trujillo-Santos J, del Campo R, Poggio R, Monreal M; RIETE Investigators. Gadelha T, et al. Thromb Res. 2010 Oct;126(4):283-6. doi: 10.1016/j.thromres.2010.06.019. Epub 2010 Jul 13. Thromb Res. 2010. PMID: 20627204

5

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O). Couturaud F, et al. Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515. Thromb Haemost. 2008. PMID: 18217158

6

Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.

Donovan AK, Smith KJ, Ragni MV. Donovan AK, et al. Thromb Res. 2013;132(6):724-8. doi: 10.1016/j.thromres.2013.09.012. Epub 2013 Sep 16. Thromb Res. 2013. PMID: 24112753

7

Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?

Franchini M, Lippi G. Franchini M, et al. Semin Thromb Hemost. 2011 Apr;37(3):275-9. doi: 10.1055/s-0031-1273091. Epub 2011 Mar 31. Semin Thromb Hemost. 2011. PMID: 21455861 Review.

8

Factor V Leiden mutation and pregnancy-related complications.

Kjellberg U, van Rooijen M, Bremme K, Hellgren M. Kjellberg U, et al. Am J Obstet Gynecol. 2010 Nov;203(5):469.e1-8. doi: 10.1016/j.ajog.2010.08.011. Am J Obstet Gynecol. 2010. PMID: 21055512

9

Factor V Leiden: a case study and review.

Slusher KB. Slusher KB. Dimens Crit Care Nurs. 2010 Jan-Feb;29(1):6-10. doi: 10.1097/DCC.0b013e3181be4985. Dimens Crit Care Nurs. 2010. PMID: 20010186 Review.

10

Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study.

El-Galaly TC, Kristensen SR, Overvad K, Steffensen R, Tjønneland A, Severinsen MT. El-Galaly TC, et al. J Thromb Haemost. 2012 Oct;10(10):2191-3. doi: 10.1111/j.1538-7836.2012.04772.x. J Thromb Haemost. 2012. PMID: 22577971 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed